What is Neteera?
Founded in 2015 and headquartered in Jerusalem, Neteera Technologies has developed advanced sensor systems capable of detecting minute skin movements. This technology is crucial for non-invasively measuring vital signs such as heart rate, heart rate variability, respiration rate, and amplitude. The company's innovation addresses a growing need for continuous, remote health monitoring solutions, positioning it within the rapidly expanding digital health and medtech sectors. Neteera's technology offers a unique value proposition by providing critical health data without requiring direct patient contact, paving the way for enhanced diagnostics and patient care.
How much funding has Neteera raised?
Neteera has raised a total of $10M across 2 funding rounds:
Unspecified
$2M
Series B
$8M
Unspecified (2016): $2M, investors not publicly disclosed
Series B (2023): $8M led by Aescuvest, Esas Private Equity, and Ankor Holding
Key Investors in Neteera
Aescuvest
Aescuvest is a platform focused on facilitating loans to companies within the German healthcare market, aiming to foster innovation and provide investors with profit-sharing opportunities in the health sector.
Esas Private Equity
Esas Private Equity is an investment firm that likely focuses on providing capital to companies with high growth potential, particularly within the technology and healthcare sectors.
Ankor Holding
Ankor Holding is an entity that participates in funding rounds, suggesting a strategic interest in companies poised for significant market impact and expansion.
What's next for Neteera?
The substantial enterprise-level funding, particularly the recent strategic investment, signals Neteera's transition into a scaling phase. This capital infusion is expected to accelerate product development, expand market reach, and enhance its technological capabilities. The company is likely to focus on further refining its sensor technology, expanding its application portfolio, and forging strategic partnerships within the healthcare ecosystem. Continued investment in R&D and commercialization efforts will be key to solidifying Neteera's position as a leader in non-contact vital sign monitoring.
See full Neteera company page
